On heels of new data, Gilead pays $455m for Asian Trodelvy rights
On the same day as it reported encouraging new data for its cancer drug Trodelvy, Gilead Sciences has agreed a deal to buy rights to […]
breast cancer
How Actionable Data and Expert Analysis Supports Service Providers, Fosters Better Care and Ensures Financial Benefits
Ashish Kachru, CEO at DataLink Approximately 42% of Medicare beneficiaries are enrolled in Medicare Advantage plans—a segment projected to reach 46% by 2025. Due to […]
Gilead claims breast cancer trial win but offers few details; drug application is filed with FDA
Gilead Sciences said it has statistically significant and clinically meaningful data from a pivotal test of its cancer drug, Trodelvy, in the most common type […]
Survival data firms up Trodelvy prospects in new breast cancer use
In the space of a couple of months, Gilead Sciences’ Trodelvy impact on overall survival (OS) in the TROPICs-02 trial in advanced breast cancer has […]
AZ gets FDA nod for Enhertu in first HER2-low cancer
The FDA has approved AstraZeneca and Daiichi Sankyo’s Enhertu as the first targeted therapy for HER2-low breast cancer, a new category of the disease that […]
FDA approval of AstraZeneca drug is first for a new group of breast cancer patients
Enhertu, a breast cancer drug from AstraZeneca and Daiichi Sankyo, is now FDA approved for treating patients whose tumors express low levels of the protein […]
Tribun Health, Mindpeak Partner on AI Diagnostic Tool for Breast Cancer for Pathologists
What You Should Know: – Tribun Health, the European leader in software development for digital pathology, is pleased to announce a strategic partnership with Mindpeak, […]
AZ, Merck get EU nod for Lynparza as adjuvant breast cancer therapy
The European Commission has cleared AstraZeneca and Merck & Co’s Lynparza as an adjuvant or neoadjuvant treatment for breast cancer, extending its lead over would-be […]
FDA verdict on Enhertu in HER2-low breast cancer due before year-end
AstraZeneca and Daiichi Sankyo will hear back from the FDA before the end of 2022 on their license application for Enhertu in HER2-low breast cancer […]
After Roe, Pregnant Women With Cancer Diagnoses May Face Wrenching Choices
Urgent questions arise about how care of pregnant women with cancer will change in states where women are unable to terminate pregnancies
Aloe Fails to Help Radiation Therapy Skin Burns
What are the effects of aloe on radiation burns caused by cancer treatment and on the cancer itself? “Worldwide attention was drawn to the possible […]
AZ, Daiichi challenge Roche with EU okay for earlier use of Enhertu
AstraZeneca and Daiichi Sankyo have claimed approval in the EU for Enhertu as a second-line therapy for HER2-positive metastatic breast cancer, moving the drug up […]
Byondis cues up US, EU decisions on breast cancer ADC in 2023
Byondis has filed its HER2-targeting antibody-drug conjugate (ADC) trastuzumab duocarmazine in the US and Europe, setting up possible approvals next year and a showdown with […]
How Effective Is Chemotherapy for Colon, Lung, Breast, and Prostate Cancers?
How effective is chemotherapy for colon, lung, breast, and prostate cancers? “Over the last several decades…medicine has waged a major war against cancer, concentrating on […]
NICE backs two new breast cancer drugs for NHS use
Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead’s Trodelvy and Novartis’ Piqray – […]
Lilly’s Verzenios gets NICE blessing for early-stage breast cancer
Thousands more people with breast cancer in England look set to be eligible for routine treatment with Eli Lilly’s Verzenios, after new guidance from NICE […]
Lilly partners with Sidekick in digital health alliance
A personalised, treatment plan for patients with breast cancer is the first digital health product to emerge from a newly-announced partnership between digital health specialist […]
Enhertu Breast Cancer Drug Results in ‘Unheard-of’ Survival Rates
For some patients with metastatic tumors not significantly affected by other forms of chemotherapy, the treatment halted their cancer’s growth.
Redefining the approach to cancer care – a mission to improve patient outcomes
Each year across Europe, 3.7 million people are diagnosed with a form of cancer, resulting in 1.9 million deaths, making cancer the second largest cause […]
ASCO22: Enhertu aces key HER2-low test in breast cancer
In February, AstraZeneca and Daiichi Sankyo teased the results of their pivotal trial of Enhertu in HER2-low breast cancer, and, at ASCO, they finally revealed […]
ASCO22: Gilead makes case for Trodelvy in advanced breast cancer
In March, Gilead Sciences reported positive results for its TROPiCS-02 study of Trodelvy, but the guarded tone of the announcement led to speculation that the […]
AstraZeneca, Daiichi Sankyo have high hopes for drug that goes low in breast cancer
During the annual meeting of the American Society of Clinical Oncology, AstraZeneca and Daiichi Sankyo reported pivotal clinical trial data showing that their partnered cancer […]
Gilead offers more detail on breast cancer drug’s trial results. Is it enough?
Gilead Sciences has more detail about breast cancer drug Trodelvy, a blockbuster hopeful it acquired two years ago. Additional data from a pivotal study were […]
At ESMO, three studies show promise of antibody-drug conjugates in breast cancer
The American Society of Clinical Oncology, or ASCO, conference is just around the corner, but one subgroup of cancer researchers just had their own gathering, […]
Angle claims FDA okay for Parsortix liquid biopsy system
After more than six years of development, Angle has scored an FDA approval for Parsortix as a diagnostic for metastatic breast cancer – the first […]
NICE endorses Magtrace diagnostic to detect breast cancer spread
Women with breast cancer in England and Wales will soon be able to access a new diagnostic based on an injectable magnetic marker liquid called […]
FDA clears wearable 3D breast ultrasound for cancer screening
Startup iSono Health said its FDA-cleared automated imaging system will make personalized whole breast imaging more accessible to women worldwide and could help improve breast […]
INVEST Pitch Perfect winner: Athelo helps patients navigate cancer journey
Athelo Health’s software is a personal coach that supports women with breast and gynecological cancers. The startup was judged co-winner in the pharmatech category during […]
Enhertu gets breakthrough tag in HER2-low breast cancer
AstraZeneca and Daiichi Sankyo have claimed a fifth breakthrough designation from the FDA for Enhertu, shortly after the showing the drug extended survival in patients […]
Cancer biotech Pheast unveils $76M to expand immunotherapy’s menu to new targets
Biotech startup Pheast is out of stealth taking a tack similar to that of cancer immunotherapy company Forty Seven, also a spinout from the Stanford […]
3 Steps to Approach & Tackle Digital Transformation in Healthcare
Michael Norring, President and CEO of GCSIT Artificial intelligence (AI) is predicted to save the US healthcare economy $150 billion by 2026. Replacing legacy systems […]
Roche breast cancer drug fails in Phase 2 following similar stumble by rival Sanofi
Experimental Roche drug giredestrant failed to meet the main goal of a Phase 2 study in advanced breast cancer. The disappointing results allow competitors to […]
Roche’s oral SERD giredestrant fails breast cancer trial
Roche revealed in its first-quarter results statement that giredestrant missed the mark in the phase 2 acelERA trial in advanced breast cancer, in what appears […]
Potential of Implementing Polygenic Risk Scores in Healthcare Systems
Dr. George Busby, co-founder and Chief Scientific Officer at Allelica The promise of personalized medicine is a world in which interventions, screening, and therapeutics are […]
Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient […]
Sanofi takes a hit as hotly tipped breast cancer drug fails trial
Shares in Sanofi were on the slide this morning after the drugmaker revealed that one of its top pipeline prospects – selective oestrogen receptor degrader […]
AZ, Merck get FDA okay for Lynparza as adjuvant breast cancer therapy
The FDA has cleared AstraZeneca and Merck & Co’s Lynparza as an adjuvant or neoadjuvant treatment for breast cancer, extending its lead over pretenders to […]
To Engage and Activate Patients, CRM Alone Isn’t Enough
Michael Linnert, Founder and CEO of Actium Health We talk about patient engagement a lot in healthcare today. But the reality is, we often don’t […]
The data are in – so will Gilead’s Trodelvy achieve its potential?
The results of Gilead’s much-anticipated TROPiCS-02 study of Trodelvy are in, and while the company says top-line data are positive, its guarded stance has rung […]
Black Female Co-founders CancerIQ Raises $14M to Improve Cancer Early Detection and Prevention
CancerIQ Co-Founders Feyi Olopade Ayodele & Olufunmilayo (Funmi) Olopade, MD What You Should Know: – CancerIQ, a Chicago-based platform powering early cancer detection and prevention across broad […]
XRHealth Secures $10M to Expand Virtual Reality Treatment in the Metaverse
What You Should Know: – XRHealth, the gateway to the healthcare metaverse, announced today that they raised $10M in funding to expand virtual healthcare treatment in the Metaverse. The […]
Predicting therapeutic outcomes in breast cancer patients: AI’s next big task
There is a need for sophisticated and accurate forecasting software tools that incorporate precision cancer care. Technology and artificial intelligence, in particular, have the potential […]
Mayo Clinic Tests Shark Cartilage Supplements for Cancer
Shark cartilage supplements carry risks, but so do many cancer treatments. The question is, do they work? When it comes to marketing unproven cancer treatments, […]
Big day for AZ, Daiichi as Enhertu aces HER2-low breast cancer trial
Already making inroads as a treatment for HER2-positive breast cancer, AstraZeneca and Daiichi Sankyo’s Enhertu has now shown efficacy in tumours that express lower levels […]
Syapse, Pfizer Extends Collaboration to Generate Real-World Evidence in Breast Cancer
What You Should Know: – Syapse, a real-world evidence company that informs cancer care, announced that it will extend its collaboration with Pfizer to generate […]
Can Alcohol Cause Cancer?
If even light drinking can cause cancer, why don’t doctors warn their patients about it? As I discuss in my video Can Alcohol Cause Cancer?, […]
When it comes to breast cancer, the right data & outreach strategy impacts lives
As health systems play catch up with backlogged – and potentially life-saving – screenings, it’s important they prioritize people at higher risk, to ensure they […]
How to Balance the Risks and Benefits of Mammograms
Fact boxes can quantify benefits and harms in a clear and accessible format. When it comes to cancer screening, doctors “have too often ignored” the […]
Doctors Tested for Basic Understanding of Mammogram Math
If doctors don’t understand health statistics, how can they possibly properly counsel patients? “In these mammography wars, rational thinking can be easily lost.” Mammograms are […]
Breast Cancer Can Grow and Spread for Decades Before “Early” Detection
“Early” detection is actually really late. Without mammograms, breast cancer may not be caught for an average of 22.8 years. With mammograms, though, breast cancer […]
Learn More Than 97% of Doctors About Lead-Time Bias
After reading this, you’ll know more than an estimated 97 percent of doctors about a critical concept called lead-time bias. While running for president of […]
AZ eyes FDA verdict on Lynparza in adjuvant breast cancer in Q1
The FDA will deliver a verdict on AstraZeneca’s PARP inhibitor Lynparza as an adjuvant treatment for breast cancer in the first quarter of next year, […]
Second FDA okay for Therapixel’s AI-based mammography tool
France’s Therapixel has secured a second FDA approval for MammoScreen, its artificial intelligence-powered software for detecting cancerous lesions in mammogram images. MammoScreen was approved last […]
THCB Spotlights: Maya Said, CEO, Outcomes4Me
Today on THCB Spotlights, Matthew Holt talks with Maya Said, the CEO of Outcomes4Me, which works in the cancer patient empowerment space. Outcomes4Me is a […]
Fewer Than One in Ten Informed About Most Serious Downside of Mammograms
What do nine in ten women say they were never told about mammograms, even though they thought they had the right to know? “Fueled by […]
Overtreatment of Ductal Carcinoma In Situ
Nine out of ten women don’t realize that some breast cancers would never have caused any problems or even become known in one’s lifetime. This […]
Those Who Claim the Greatest Benefit From Mammograms May Ironically Suffer the Most Harm
The mammogram paradox is that women who are harmed the most, are the ones who claim the greatest benefit. While false-positive results, pain during the […]
Personalized Screening is Key to Breast Imaging AI Market Reaching $205M by 2025
Dr. Sanjay M. Parekh Ph.D. , Sr Market Analyst at Signify Research Ltd. As October draws to a close, so does Breast Cancer Awareness Month […]
How Much Cancer Do Mammograms Cause?
What is the risk-benefit ratio of the cancers picked up by mammograms and the cancers caused by mammograms? Over the last few decades, our radiation […]
Seagen’s breast cancer drug Tukysa turned down by NICE
NICE has decided not to recommend Seagen’s orally-active HER2 inhibitor Tukysa for advanced breast cancer in draft guidance, saying it isn’t a cost-effective use of […]
Do Mammograms Have to Be Painful?
Excessive breast compression during mammography may not improve image quality and can cause unnecessary pain. False-positive results have been described as “the most frequent harm” […]
Most Women May Experience at Least One False-Positive Mammogram
Odds are most women will get at least one false-positive mammogram, but, thankfully, most women who are called back for further testing of a suspicious […]
How Is It Possible That Mammograms Don’t Actually Save Lives?
For every life saved by mammography, as many as two to ten women are overdiagnosed and unnecessarily turned into breast cancer patients with all of […]
Why Doctors Should Not Encourage Breast Self-Exams
Various health organizations offer clashing mammogram recommendations that range from annual mammograms starting at age 40 to eliminating routine mammograms altogether. Who can you trust? […]
Cáncer sin quimioterapia: una revolución silenciosa
Un número cada vez mayor de pacientes con cáncer, especialmente los de mama y pulmón, se libran del temido tratamiento en favor de otras alternativas.
Enhertu nabs speedy FDA review for earlier use in breast cancer
Hard on the heels of impressive new data for Enhertu as a second-line therapy for breast cancer, AstraZeneca and Daichi Sankyo have claimed FDA breakthrough […]
Cáncer sin quimioterapia: una revolución silenciosa
Un número cada vez mayor de pacientes con cáncer, especialmente los de mama y pulmón, se libran del temido tratamiento en favor de otras alternativas.
Why Are Mammogram Guidelines Conflicting?
When women are fully informed about the risks and benefits of mammograms, 70 percent may choose not to get screened. You may be in that 30 […]
Cancer Without Chemotherapy: ‘A Totally Different World’
A growing number of cancer patients, especially those with breast and lung cancers, are being spared the dreaded treatment in favor of other options.
90% of Women Appear Misinformed About Mammograms
Most women are just being told what to do, rather than being given the facts needed to make a fully informed decision. “Selling cancer screening can be […]
ESMO21: Roche’s giredestrant takes stage in battle of the oral SERDs
Roche has revealed the first phase 2 clinical data with giredestrant, one of a clutch of new selective oestrogen receptor degraders (SERDs) hoping to provide […]
The Effects of Nutritional Yeast for Cancer
How can the beta glucan fiber in brewer’s, baker’s, and nutritional yeast improve wound healing and, potentially, anti-cancer immunity? My video Benefits of Nutritional Yeast for Cancer opens with […]
Evidence lacking for AI-based breast cancer screening
A review of 12 studies about AI systems used to screen patients for breast cancer found that they lacked evidence to prove that they would […]
Debunking 4 myths about cancer clinical trials: The unsung hero of breast cancer research
Clinical trials are the safest and most trusted route for identifying new breast cancer treatments, and the more research that can be done, the closer […]
Soy Phytoestrogens for Menopausal Symptoms
Does soy food consumption explain why Japanese women appear to be so protected from hot flash symptoms? When women hit menopause and their ovaries shut down, the […]
NICE changes stance on Lilly’s breast cancer dug Verzenio
After rejecting Eli Lilly’s Verzenio for breast cancer therapy earlier this year, NICE has relented, recommending the drug for routine NHS use alongside hormonal therapy […]
Breast cancer drug approved for NHS after maker agrees discount
Reversal of earlier rejection by Nice of abemaciclib – known as Verzenios – is welcomed by campaigners A breast cancer drug that was rejected for […]
HER2 heats up as Seagen licenses RemeGen ADC for $2.6bn
Seagen is a specialist in antibody-drug conjugates, but has looked to Chinese biotech RemeGen for a HER2-targeting candidate that could challenge rival drugs from AstraZeneca/Daiichi […]
Pfizer commits $1B to Arvinas for share of protein degrading breast cancer drug
Arvinas’ early clinical data for its targeted protein degradation drug for breast cancer drew partnering interest from several companies. Pfizer beat them all with a […]
Pfizer puts up $1bn to buy into Arvinas breast cancer programme
Pfizer has pledged a whopping $11 billion upfront for rights to an Arvinas drug for breast cancer from its protein degrader platform, which harnesses cells’ […]
ViewPoints Interview: Q BioMed’s Denis Corin Shares Insights on the Agreement to Serve US Department of Defense and Veterans Affairs
In an interview with PharmaShots, Denis Corin, Chief Executive Officer and Chairman of the Board at Q BioMed share his views on the supply agreement […]
Dr. Amit Agarwal Interview
Sonam: Hello everyone, today we have on our panel discussion round doctor Amit Agarwal with us who is Director Medical Oncology from Fortis Hospital Shalimar […]
Shining a light on gaps in breast cancer care: A call for increased equity
As an industry, we should be proud of all that we have accomplished in making precision medicine a reality, whether it has been through advances […]
ASCO 2021 recap: Lynparza’s lift, Grail goes on, LAG validation & more
The American Society of Clinical Oncology’ annual meeting featured news highlights from the Merck, Novartis, and other drug giants. Meanwhile, some small biotechs rode the […]
ASCO21: Lynparza aces adjuvant breast cancer therapy trial
AstraZeneca and Merck & Co’s Lynparza is primed for even wider use in the treatment of breast cancer after a phase 3 trial showed it […]
ViewPoints Interview: Daiichi Sankyo’s Ken Keller Shares Insights on NICE Recommendation for Enhertu in HER2 Positive Breast Cancer
In an interview with PharmaShots, Ken Keller, President and Chief Executive Officer at Daiichi Sankyo and Global Head of the Daiichi Sankyo Oncology Business shared his […]
Off Our Chests: No Secrets Left Behind
By CHADI NABHAN She was a successful corporate lawyer turned professional volunteer and a housewife. He was a charismatic, successful, and world-renowned researcher in gastrointestinal […]
AZ/Daiichi unveil data from TNBC hopeful datopotamab deruxtecan
AstraZeneca and Daiichi Sankyo have revealed new data from datopotamab deruxtecan in triple negative breast cancer (TNBC) – and although it’s from a small patient […]
Are Avocados Associated with Greater Risk or Reduced Risk of Cancer?
Avocado consumption can improve artery function, but what effect might guacamole have on cancer risk? In my last video about avocados, The Effects of Avocados […]
Natural Dietary Treatments for Fibroids
The same diet that helps regulate hormones in women may also reduce exposure to endocrine-disrupting pollutants. Fibroids are the most common benign tumors in women. […]
Tecentriq can stay as therapy for triple-negative breast cancer, FDA experts say
Roche’s Tecentriq can stay on the US market as a therapy for triple negative breast cancer, advisers to the FDA have said as part of […]
Enhertu cleared for NHS use via Cancer Drugs Fund
NICE has recommended the use of AstraZeneca and Daiichi Sankyo’s Enhertu in draft guidance, the first time the drug has been commissioned in any European […]
Should You Get an Annual Health Check-Up?
What are the risks and benefits of getting an annual check-up from your doctor? Physicians and patients have come to expect the annual check-up as […]
Gilead scores US approval for breast cancer drug that wowed ESMO
Gilead’s $21 billion purchase of Immunomedics and its potential blockbuster Trodelvy continues to pay off, as the drug has now been approved by the FDA […]
Helpful Foods to Support People with Autism
The sulforaphane found in five cents’ worth of broccoli sprouts has been shown to benefit autism in a way no drug ever has in a […]
José Baselga, Who Advanced Breast Cancer Treatments, Dies at 61
He was a top executive at Memorial Sloan Kettering before resigning over payments from health care companies. He went on to lead cancer research at […]
José Baselga, Who Advanced Breast Cancer Treatments, Dies at 61
He was a top executive at Memorial Sloan Kettering before resigning over payments from health care companies. He went on to lead cancer research at […]
José Baselga, Who Advanced Breast Cancer Treatments, Dies at 61
He was a top executive at Memorial Sloan Kettering before resigning over payments from health care companies. He went on to lead cancer research at […]
José Baselga, Who Advanced Breast Cancer Treatments, Dies at 61
He was a top executive at Memorial Sloan Kettering before resigning over payments from health care companies. He went on to lead cancer research at […]
José Baselga, Who Advanced Breast Cancer Treatments, Dies at 61
He was a top executive at Memorial Sloan Kettering before resigning over payments from health care companies. He went on to lead cancer research at […]
Are Lectins in Food Good or Bad for You?
Might lectins help explain why those who eat more beans and whole grains have less cancer? Lectins are to blame for the great “white kidney […]
FDA rejects Athenex’s oral chemotherapy, asks for another clinical trial
Athenex’s bid to offer an oral version of an intravenous chemotherapy has stalled after the FDA rejected the drug. Among the remedies proposed by the […]
Novartis Piqray(R) – First and only treatment specially for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer receives HSA approval
Novartis announced the Health Sciences Authority (HSA) has approved* Piqray®, an α-specific class I phosphatidylinositol-3-kinase (PIK3CA) inhibitor, for the treatment of postmenopausal women, and men, with […]
Life-extending drug for incurable breast cancer approved for NHS use
About 3,300 women a year may benefit from decision to approve ribociclib Women with incurable advanced breast cancer will be able to get a drug […]
NICE okays regular NHS funding for Novartis’ breast cancer drug Kisqali
NICE has recommended moving Novartis’ Kisqali (ribociclib) from interim funding arrangements to regular NHS reimbursement for certain previously treated breast cancer patients. In the final […]
Filing beckons as Lynparza hits the mark in adjuvant breast cancer
AstraZeneca’s PARP inhibitor Lynparza has shown a clinical benefit when given as an adjuvant for early breast cancer, according to the data monitoring body for […]
A Patient Engagement Strategy Needs to Deliver a Holistic Experience
Chris Evanguelidi, Director, Enterprise Healthcare Market for Redpoint Global Inc. Researchers from Johns Hopkins published a study in October on the impact of the pandemic […]
Volpara Acquires Breast Cancer Risk Assessment Platform CRA Health for $18M
What You Should Know: – Volpara Health, an integrated breast care platform assisting in the delivery of personalized patient care has acquired breast cancer risk […]
Arsenic in Rice Milk, Rice Krispies, and Brown Rice Syrup
I recommend people switch away from using rice milk For kids and teens, the amount of arsenic flowing through their bodies was found to be […]
Trial results extend add to uses for Exact Sciences test
The genomic test, known as Oncotype DX, can help predict whether women with certain forms of breast cancer will benefit from chemotherapy — and those […]
MacroGenics’ HER2 breast cancer drug Margenza approved in US
MacroGenics’ HER2-targeted breast cancer drug Margenza has been approved by the FDA, challenging several recently approved drugs with a narrow efficacy edge over Roche’s Herceptin […]
Daiichi Sankyo, AZ close on EU approval of Enhertu for breast cancer
Daiichi Sankyo and AstraZeneca could be just weeks away from an EU approval for their antibody-drug conjugate (ADC) for breast cancer – Enhertu – which […]
The Antioxidant Power of Açaí vs. Apples
There are so many açaí products on the market now, from frozen pulp in smoothie packs to freeze-dried powder and supplements. How is it eaten […]
Zymeworks and ALX Oncology Collaborate to Evaluate Zanidatamab + ALX148 for Advanced HER2‑Expressing Breast Cancer
Shots: Zymeworks will conduct a P-Ib study to assess the safety and efficacy of the combination of zanidatamab and ALX148 in a two-part study The […]
Merck & Co buys cancer biotech VelosBio for $2.75bn
Merck & Co has agreed to buy California biotech VelosBio and its experimental cancer drug for $2.75 billion in cash. Known as MSD outside North […]
ANGLE raises £20m, eyes opportunity in immunotherapy trials
Liquid biopsy company ANGLE has raised £20m through a conditional placing on the London Stock Exchange which will be used to expand commercial opportunities. ANGLE’s […]
Toxic positivity and grief: The reality of living through cancer
Cancer doesn’t end when treatment stops – it’s a lifelong journey and people need support throughout, says patient advocate Megan-Claire Chase. No one gets through […]
Fujifilm & Volpara Partner to Help Clinicians Determine Patient Breast Density
What You Should Know: – FUJIFILM Medical Systems U.S.A., Inc. and Volpara Solutions announced the extension of their partnership to provide mammography facilities and clinicians […]
How to Treat Polycystic Ovary Syndrome (PCOS) with Diet
Given the role that oxidant free radicals are thought to play in aging and disease, one reason fruits and vegetables may be so good for […]
AWS, PHDA Collaborate to Develop Breast Cancer Screening and Depression Machine Learning Models
What You Should Know: – Amazon Web Services (AWS) and the Pittsburgh Health Data Alliance (PHDA) announce a collaboration to produce more accurate machine learning […]
The Role of Meat and Dairy Viruses in Cancer
“Nearly 20% of cancer cases arising worldwide can be linked to infectious agents, including viruses.” Seven viruses are now conclusively tied to human cancers, and, […]
UK medical journals spar over breast cancer screening study
Screening women for breast cancer in their 40s rather than their 50s could save lives, say the authors of a new Lancet Oncology study, although […]
What Explains the Egg-Cancer Connection
The reason egg consumption is associated with elevated cancer risk may be the TMAO, considered the “smoking gun” of microbiome-disease interactions. “We are walking communities […]
Samsung Bioepis Launches Ontruzant (trastuzumab, biosimilar) for Early and Metastatic HER2-Overexpressing Breast Cancer in Brazil
Shots: The company launches its first oncology treatment Ontruzant (trastuzumab), a biosimilar referencing Herceptin in Brazil. The biosimilar has received ANVISA’s approval for the treatment […]
Armpit Shaving and Breast Cancer
Shaving before applying underarm antiperspirants can increase aluminum absorption. Could this explain the greater number of tumors and the disproportionate incidence of breast cancer in […]
Roche Receives the US FDA’s Approval for VENTANA HER2 Dual ISH Test as CDx to Identify Breast Cancer
Shots: The US FDA has approved the new VENTANA HER2 Dual ISH DNA Probe Cocktail assay to detect HER2 biomarker in BC and as a […]
Henlius and Accord’s Zercepac (trastuzumab, biosimilar) Receive the EMA Approval for HER2-Positive Breast Cancer and Gastric Cancer
Shots: The approval is based on comparative quality studies, clinical studies including preclinical data and resulted in bio-similarity, comparable efficacy and safety of Zercepac (HLX02) […]
Zebra Medical Receives the US FDA’s Approval for its HealthMammo Mammography Tool
Shots: The US FDA has granted 510 (k) clearance to HealthMammo for boosting early detection of breast cancer in mammograms The tool utilizes the AI […]
AstraZeneca, Daiichi Sankyo sign $6B deal for antibody-drug conjugate
The companies will share development and commercialization of DS-1062 in solid tumors. They already have a similar deal in place, the $6.9 billion agreement signed […]
AstraZeneca inks $6bn cancer drug deal with Daiichi Sankyo
AstraZeneca has begun a new agreement with Daiichi Sankyo to develop and market an antibody to treat cancer, worth up to $6 billion. The deal […]
Daiichi Sankyo Signs a Research Agreement Gustave Roussy for DS-1062 and Patritumab Deruxtecan to Treat Lung and Breast Cancer
Shots: Gustave Roussy to receive funding and support from Daiichi Sankyo for integrative research program including clinical, translational, and preclinical studies for DS-1062 and patritumab […]
What Does Drinking Soy Milk Do to Hormone Levels?
The vast majority of breast cancers start out hormone-dependent, where estradiol, the primary human estrogen, “plays a crucial role in their breast cancer development and […]
Are the BPA-Free Plastics Like Tritan Safe?
Do BPA-free plastics such as Tritan, have human hormone-disrupting effects? And what about BPS and BPF? Recent human studies indicate that exposure to the plastics […]
How to Treat Endometriosis with Diet
“Endometriosis is a major cause of disability and compromised quality of life in women and teenage girls.” It “is a chronic disease which is under-diagnosed, […]
What to Eat and Avoid for Women with BRCA Gene Mutations
Five studies have been performed on breast cancer survival and soy foods involving more than 10,000 breast cancer patients, and together they found that those […]
